These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I. Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756 [TBL] [Abstract][Full Text] [Related]
4. Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population. Best I; López G; Talledo M; MacNamara A; Verdonck K; González E; Tipismana M; Asquith B; Gotuzzo E; Vanham G; Clark D AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1207-12. PubMed ID: 21453202 [TBL] [Abstract][Full Text] [Related]
5. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy. Nakamura T Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340 [TBL] [Abstract][Full Text] [Related]
6. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814 [TBL] [Abstract][Full Text] [Related]
7. HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load. Tanaka M; Takenouchi N; Arishima S; Matsuzaki T; Nozuma S; Matsuura E; Takashima H; Kubota R Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999966 [TBL] [Abstract][Full Text] [Related]
8. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus]. Carod-Artal FJ Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063 [TBL] [Abstract][Full Text] [Related]
9. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load. de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF; J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636 [TBL] [Abstract][Full Text] [Related]
10. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders. Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872 [TBL] [Abstract][Full Text] [Related]
11. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259 [TBL] [Abstract][Full Text] [Related]
12. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders. Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845 [TBL] [Abstract][Full Text] [Related]
13. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP. Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429 [TBL] [Abstract][Full Text] [Related]
14. Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis. Nakamura T Ann Med; 2000 Dec; 32(9):600-7. PubMed ID: 11209967 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection. Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858 [TBL] [Abstract][Full Text] [Related]
17. Balance Impairments in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection. Vasconcelos BHB; Callegari B; Costa KHA; Barroso TGCP; Sousa RCM; Saunier G; Xavier MB; Souza GS Sci Rep; 2019 Aug; 9(1):11456. PubMed ID: 31391511 [TBL] [Abstract][Full Text] [Related]
18. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis. Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163 [TBL] [Abstract][Full Text] [Related]
19. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847 [TBL] [Abstract][Full Text] [Related]
20. Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers. Chaves DG; Sales CC; de Cássia Gonçalves P; da Silva-Malta MC; Romanelli LC; Ribas JG; de Freitas Carneiro-Proietti AB; Martins ML J Med Virol; 2016 Aug; 88(8):1438-47. PubMed ID: 26800845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]